"CD11b Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CD antigen that contains a conserved integrin I-domain which is involved in ligand binding. When combined with CD18 the two subunits form MACROPHAGE-1 ANTIGEN.
| Descriptor ID |
D039481
|
| MeSH Number(s) |
D12.776.395.550.200.074.750 D12.776.543.550.200.093.750 D12.776.543.750.705.408.100.150 D12.776.543.750.705.833.062 D23.050.301.350.074.049
|
| Concept/Terms |
CD11b Antigen- CD11b Antigen
- Antigen, CD11b
- ITGAM Protein
- Integrin alpha M
- alpha M, Integrin
- CD11b Antigens
- Mo1 Antigen
- Antigen, Mo1
- Mo1 Glycoprotein
- Integrin alphaM
- alphaM, Integrin
- alphaM Integrin
- Integrin, alphaM
- Complement Component Receptor 3, alpha
- Antigens, CD11b
|
Below are MeSH descriptors whose meaning is more general than "CD11b Antigen".
Below are MeSH descriptors whose meaning is more specific than "CD11b Antigen".
This graph shows the total number of publications written about "CD11b Antigen" by people in this website by year, and whether "CD11b Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD11b Antigen" by people in Profiles.
-
Association of Monocyte Migration Marker CD11b With Pulmonary Function in People Living With HIV. J Acquir Immune Defic Syndr. 2021 03 01; 86(3):344-352.
-
A Genetic Model of Constitutively Active Integrin CD11b/CD18. J Immunol. 2020 11 01; 205(9):2545-2553.
-
Peroxisome Proliferator-Activated Receptor-d Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis. J Immunol. 2019 11 15; 203(10):2588-2601.
-
CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest. 2017 Apr 03; 127(4):1271-1283.
-
Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. J Am Soc Nephrol. 2015 Nov; 26(11):2753-64.
-
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta. 2013 Jun; 1830(6):3696-710.
-
Species-specific biological effects of FGF-2 in articular cartilage: implication for distinct roles within the FGF receptor family. J Cell Biochem. 2012 Jul; 113(7):2532-42.
-
Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor ?. Neurochem Res. 2012 Aug; 37(8):1718-29.
-
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal. 2011 Sep 06; 4(189):ra57.
-
CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation. J Immunol. 2009 Jan 01; 182(1):623-35.